论文信息 - A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA) - 字舞流文

A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)

F. Marmé | S. Loibl | V. Nekljudova | Marcus Schmidt | S. Kümmel | G. von Minckwitz | S. Costa | V. Müller | E. Grischke | B. Gerber | D. Bauerschlag | N. Maass | C. Mundhenke | J. Barinoff | D. Herr | M. Thill | C. Schumacher | P. Krabisch | J. Bischoff | K. Lübbe | S. Seiler